MID in oncology also enhances treatment adherence and improves patient outcomes, according to Kenneth Komorny, PharmD, BCPS.

In this episode titled, Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical ...

In this clip, Katherine Tobon, PharmD, BCOP, of Moffitt Cancer Center, defines medically integrated dispensing (MID), how it is implemented in oncology care settings, and the associated advantages and ...

As stroke systems of care evolve, clinicians are increasingly torn between the known safety of traditional, aggressive ...

The rationale behind the treatment is that, because genetic FXI deficiency has been linked with reduced risk of ischemic ...

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Kenneth Komorny, PharmD, BCPS, is vice president and chief pharmacy officer at Moffitt Cancer Center in Tampa, Florida. MID ...

First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, ...

In combined analysis (n = 39), the average wound closure rate was 98%, and all 19 patients previously diagnosed for potential ...

Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...

Elevating CMS oversight operationalizes Any Willing Provider by mandating “reasonable and relevant” participation terms, ...

Overlooked or underestimated risk factors may warrant more consideration in stroke prevention and epidemiology, according to ...